Thomas Round 💙

GP @BBB_health AcademicCL @NIHRresearch @KingsMedicine Assoc Editor @BJGPJournal @rcgp ;exTrustee @Barts_Charity

[ThesalariedGP @zaynhasn]

Mind boggling that 1 million people in the UK have been deregistered - some by NHS England own admission even if they have had a GP consultation. The process is ridiculously flawed. This is a scandal and no mention anywhere in mainstream press.

[John Gillespie 🌱 @DrGillespie_GP]

@DrSteveTaylor @DianaJohnsonMP @YvetteCooperMP @andyburnham @VictoriaTzB @DavidGWrigley @DrSelvarajah @rcgp It is also disproportionately affecting GPs in the most deprived areas. Thanks Labour government! https://t.co/kB6qoPiggA @ShaunLintern @andyburnham @ZackPolanski

[John Gillespie 🌱 @DrGillespie_GP]

GP list cleansing will take out over £100m a year of core funding out of general practice in England. I used Claude to analyse the data on how this is affecting GP practices in deprived areas

It is not being taken evenly. Per patient, practices in the most deprived areas are losing twice as much as the least deprived.

https://t.co/sD1JUkvpxB

[Neena Jha @DrNeenaJha]

What fresh hell is this?

The chair of NHS England is arguing the case to bring in corridor care to GP practices….by using waiting rooms for patient care. Has she ever sat in a GP waiting room?!

Where exactly will patients wait…on the roof?!

[Thomas Round 💙 @drtomround]

@KarlTurnerMP Hi @KarlTurnerMP thanks for highlighting - but important note this is ZERO extra money. It’s £ already sucked out of cash strapped general practice. We are functioning on less than 8% of NHS budget to deliver 90% of appointments. Where is left shift promised? @YvetteCooperMP

[Andy Pow @medicaccountant]

Brazen daylight robbery by NHS England. Announcing new frailty investment …. Additional work funded out of money they will take from existing core funding over the next 4 months. Does anyone there have a clue how GP practices pay for things 🤬@DrSteveTaylor

[Thomas Round 💙 @drtomround]

To be clear this is NO NEW £. At least £40m already sucked out of barely surviving general practice due to crazy and unaccountable list cleansing - potentially denying transient and vulnerable people access https://t.co/Oj2jWjipVl @TheBMA

[NHS England @NHSEngland]

Up to 300,000 vulnerable patients will receive extra GP support this winter to help keep them well and reduce avoidable hospital admissions.

A new £40 million programme will support people with conditions including heart disease, frailty and COPD.

➡️ https://t.co/HQwKHZFler

[Steven Salzberg 💙💛 @StevenSalzberg1]

Nice: PubMed has stopped indexing Nature's @SciReports because it's not really a peer-reviewed journal: they accept almost everything as long as you pay their exhorbitant $2850 fee. Just a cash cow for @SpringerNature. PubMed should do more of this! https://t.co/fy2f5TmWU6

[Thomas Round 💙 @drtomround]

@AmJGastro new paper

https://t.co/QV9vRls3dP
Diagnostic Accuracy of Capsule Sponge for Barrett's Esophagus in GORD: A Systematic Review and Meta-Analysis

sensitivity for BE 0.87, specificity 0.88, negative predictive value 0.96 -an effective, safe & well tolerated test in 10min

[Dr Steve Taylor @DrSteveTaylor]

#TeamGP this might be of interest to the 450 GP practices who lost their websites

https://t.co/aBEmFMlPo8

[The Academy @TheAcademy]

There was something extraordinary about the way Sir Patrick Stewart could make even the most powerful characters feel profoundly human.

Whether commanding the bridge of the Enterprise or guiding a generation of young mutants, Sir Patrick Stewart brought a tenderness to his characters that made us feel we knew them. Behind that unmistakable voice was an actor who understood that even the greatest heroes could be uncertain, that strength could exist alongside vulnerability, and that compassion was never a weakness.

Over a career spanning more than six decades, his performances became woven into the lives of generations who grew up watching him. As Captain Jean-Luc Picard, Professor Charles Xavier, and so many others, he left us with characters we loved, lessons we carried, and memories we'll always treasure.

[caroline rayment 💙 @RaymentCaroline]

@TomHCalver Read your article - I’m an NHS GP - the point of your article should have been that increasing access DOES NOT equate to more capacity. With no new funding we can’t employ more Dr’s so no more appointments - rearranging deckchairs on the titanic springs to mind - not GP fault

[Paul Sax @PaulSaxMD]

PowerPoint deadline season in academic medicine, w/ an inbox overflowing with "friendly reminders" to submit slides and other stuff weeks before my talks! Naturally, instead of finishing those slides, I wrote this to complain about it. Free link in replies. @NEJM

[NEJM @NEJM]

Original Article: Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis (NHS-Galleri trial) https://t.co/6gXCDymzRy

Editorial: A Step in the Search for the Elusive Holy Grail of Early Detection of Cancer https://t.co/jDmoMv2ZhM

#Oncology #Genetics

[NEJM @NEJM]

This randomized trial examined whether adding a multicancer early-detection blood test to usual care reduces late-stage cancer diagnoses in adults 50 to 77 years of age. Research findings from the NHS-Galleri trial are summarized in a new Quick Take video. https://t.co/u76u9DS4rl

[The BMJ @bmj_latest]

Compared with no use of hormone therapy, oral menopausal hormone therapy was associated with increased venous thromboembolic risk regardless of dosage & treatment duration, finds study.

No increased thrombotic risks were observed with transdermal therapy
https://t.co/OyJmdTklhR

[Thomas Round 💙 @drtomround]

Great to be part of this trail blazing NHS Galleri RCT of multi cancer early detection (MCED) test . Reduction in late stage 4 at diagnosis and emergency presentations @NEJM https://t.co/hTbRZL5xQ7 @petersasieni @QMUL @QMUL_WIPH_CPDD @CharlesSwanton @richarddneal @kingsmedicine

[NEJM @NEJM]

Original Article: Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis (NHS-Galleri trial) https://t.co/6gXCDymzRy

Editorial: A Step in the Search for the Elusive Holy Grail of Early Detection of Cancer https://t.co/jDmoMv2ZhM

#Oncology #Genetics

[Nature Medicine @NatureMedicine]

New studies provide evidence on performance, safety & implementation of the #Galleri multi-cancer early detection test, underscoring the next challenge: demonstrating population-level benefit.
Catherine Marinac & colleagues @DanaFarber discuss the data:
https://t.co/VuqPIottCc

[GRAIL @GrailBio]

Detailed peer-reviewed results from the NHS-Galleri trial are now published in @NEJM and @NatureMedicine, providing clinical utility and performance data.

These results reflect GRAIL’s commitment to setting a high bar for MCED evidence—rigorously demonstrating Galleri’s potential to reduce late-stage diagnoses and find more cancers earlier.

#EarlyCancerDetection #CancerScreening #MCED

Learn more:
New England Journal of Medicine: https://t.co/B8ai7b7TZF
Nature Medicine: https://t.co/VZopLcjns6

Rx Only. See Important Safety Information: https://t.co/btAykl3HJ0

[NEJM @NEJM]

In a trial of a blood-based multicancer early-detection test added to usual care, the incidence of stage III or IV cancer after three rounds of screening did not differ significantly from that with usual care alone. Full NHS-Galleri trial results: https://t.co/6gXCDymzRy

Editorial: A Step in the Search for the Elusive Holy Grail of Early Detection of Cancer https://t.co/jDmoMv2ZhM